查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829248

2025年全球智慧胰島素筆市場報告

Smart Insulin Pens Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，智慧胰島素筆市場規模強勁成長，從2024年的1.1億美元成長到2025年的1.1億美元，複合年成長率為6.1%。這段時期的成長歸因於糖尿病盛行率的上升、新興市場的強勁經濟年複合成長率、老年人口的成長、醫療支出的增加以及公共醫療保險改革。

智慧胰島素筆市場規模預計在未來幾年強勁成長，到2029年將達到1.5億美元，複合年成長率為7.0%。預測期內的成長可歸因於疾病負擔的增加、政府措施以及技術進步。預測期內的主要趨勢包括與科技公司的合作、智慧胰島素給藥設備、新型胰島素給藥方式、物聯網整合以及併購的增加。

智慧胰島素筆是指一種用於監測和記錄給藥資訊（如劑量、時間、類型等）的胰島素傳輸裝置。此外，這些設備還可以提供報告等功能，以便與醫療保健專業人員共用。

智慧胰島素筆有兩種類型：第一代和第二代（配備藍牙或USB連接）。第二代智慧型胰島素筆配備藍牙或USB連接功能，方便更密切的監測。這些筆有預填充和可重複使用兩種版本，可用於治療第1型和第2型糖尿病。智慧胰島素筆的終端使用者多種多樣，包括醫院、診所、門診手術中心和居家醫療機構。

2025年春季，美國關稅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供智慧胰島素筆市場統計數據，包括全球智慧胰島素筆市場規模、各地區市場佔有率、競爭對手的市場佔有率、智慧胰島素筆市場細分、市場趨勢和商機，以及在智慧胰島素筆行業取得成功所需的數據。本智慧胰島素筆市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全方位觀點。

未來五年7.0%的預測成長率，較我們先前對該市場的預測略有下降0.5%。下降的主要原因是美國與其他國家之間關稅的影響。這種影響將直接影響美國，導致劑量追蹤微處理器和精密注射器的供應鏈中斷，以及來自愛爾蘭和以色列的關鍵進口產品，可能會推遲糖尿病管理解決方案的推出。此外，互惠關稅以及貿易緊張局勢和限制升級對全球經濟和貿易的負面影響也將對美國產生更廣泛的影響。

與胰島素管瓶或注射器相比，使用胰島素筆更容易達到精準的胰島素給藥。例如，對於需要在學校上課期間注射胰島素的兒童或視力受損的糖尿病患者，胰島素筆可以透過劑量刻度盤預設精確劑量，確保注射時劑量準確。兒童胰島素筆，例如諾和諾德的 Echo Plus，允許最多 30 個單位的半劑量給藥。此外，禮來的 HumaPen LaXura HD 允許半劑量給藥，而諾和諾德的 NovoPen Junior 即使在半劑量下也能進行微調，從而實現精準的胰島素給藥。智慧胰島素筆提供的劑量調整和給藥準確性可以防止劑量過量和劑量不足，從而推動智慧胰島素筆需求的預期成長，並推動市場成長。

預計全球糖尿病人口的成長將在未來幾年顯著推動智慧胰島素筆市場的成長。糖尿病人口包括被診斷患有糖尿病的人，糖尿病是一種以血糖值升高為特徵的慢性疾病。智慧胰島素筆透過提供準確的胰島素劑量追蹤、提醒和數據整合來增強糖尿病管理，提高糖尿病患者的治療依從性和整體血糖控制。例如，2022 年 7 月，總部位於比利時的非營利組織國際糖尿病聯盟報告稱，2022 年全球約有 5.37 億成年人將患糖尿病。預計到 2030 年這一數字將增至 6.43 億，到 2045 年將增至 7.83 億。因此，全球糖尿病人口的成長正在推動智慧胰島素筆市場的成長。

下一代智慧胰島素筆超越了簡單的記憶體存儲，能夠協助進行個人化劑量計算、持續追蹤血糖濃度，並連接到智慧型手機應用程式進行數據視覺化。 2022年4月，美國跨國製藥公司禮來公司推出了Tempo®個人化糖尿病管理平台。此綜合系統旨在改善第1型和第2型糖尿病成年人的糖尿病自我管理。 Tempo智慧按鈕是一種可重複使用的設備，可連接到Tempo筆上以捕獲和傳輸胰島素劑量數據，而TempoSmart™應用程式則記錄這些劑量數據並提供個人化教育和用藥提醒。

為了最佳化市場收益，智慧胰島素筆市場的主要企業正策略性地專注於推出易於使用的胰島素筆，例如 NovoPen 6 和 NovoPen Echo Plus。這些自行注射筆會在每次注射後自動記錄胰島素注射資訊。例如，2022 年 3 月，丹麥製藥公司 Novo Nordisk A/S 推出了首款智慧胰島素筆—NovoPen 6 和 NovoPen Echo Plus。這些筆記錄胰島素注射的時間和劑量等詳細資訊，並透過近距離場通訊(NFC) 將數據上傳到應用程式。這些筆有助於傳輸到患者首選的糖尿病應用程式，從而實現與醫療保健提供者的數據共用。它們與智慧型手機、平板電腦、個人電腦、血糖值監測儀和其他支援 NFC 的裝置相容。

2023年10月，諾和諾德以1.645億美元收購了法國醫療設備公司Biocorp，該公司專門從事藥物輸送系統和醫療設備的開發和製造。此次收購預計將使諾和諾德能夠進一步投資Biocorp的設備開發，並加速公司在設備和輸送解決方案方面的雄心壯志。

智慧胰島素筆市場的主要企業包括 Companion Medical、Novo Nordisk A/S、F. Hoffmann-La Roche AG、Emperra GmbH E-Health Technologies、Diamesco Co.Ltd.、Digital Medics Pvt Ltd.、Bigfoot Biomedical、Diabnext、Insulet Corporation、江蘇德福醫療有限公司、Sanoon.Iconn. Johnson、COVIDien Healthcare、Philips Healthcare India、山東威高集團醫用聚合物有限公司、Yuwell medical equipment & supply Co.、Terumo、NIPRO、Olympus Medical Systems、Nihon Koden、Medtronic PLC、Ypsomed Holding AG、Berlin-Chemie AG、Patabors Penetand、Delk、Getand Lt. Diabetes Care, Inc.

2024年，智慧胰島素筆市場最大的地區是北美。就全球智慧型胰島素筆市佔率而言，西歐是第二大地區。智慧胰島素筆市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。

智慧胰島素筆市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、加拿大和西班牙。

智慧胰島素筆市場涵蓋第一代和第二代（支援藍牙和USB連接）等設備的銷售。該市場的價值指的是出廠價，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球智慧型胰島素筆：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球智慧型胰島素筆市場：成長率分析
  • 全球智慧胰島素筆市場表現：規模與成長，2019-2024
  • 全球智慧胰島素筆市場預測：規模與成長，2024-2029年，2034年
  • 全球智慧胰島素筆：總目標市場（TAM）

第6章 市場細分

  • 全球智慧型胰島素筆市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 第一代筆
  • 第二代筆
  • 全球智慧胰島素筆市場：按使用者性別、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 預填充
  • 可重複使用的
  • 全球智慧型胰島素筆市場應用、表現及預測（2019-2024、2024-2029、2034）
  • 1型糖尿病
  • 2型糖尿病
  • 全球智慧型胰島素筆市場終端用戶、績效及預測（2019-2024、2024-2029、2034）
  • 醫院和診所
  • 門診手術中心
  • 居家照護
  • 全球智慧胰島素筆市場：第一代筆細分、類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 具有標準功能的基本智慧胰島素筆
  • 輕鬆連接到行動應用程式，追蹤和記錄胰島素劑量
  • 全球智慧胰島素筆市場：第二代筆細分、類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 具有先進功能的高階智慧胰島素筆
  • 與醫療保健專業人員和看護者即時共用數據
  • 領先的綜合糖尿病管理行動應用程式

第7章 區域和國家分析

  • 全球智慧胰島素筆市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球智慧胰島素筆市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 智慧胰島素筆市場：競爭格局
  • 智慧胰島素筆市場：公司簡介
    • Companion Medical
    • Novo Nordisk A/S
    • F. Hoffmann-La Roche AG
    • Emperra GmbH E-Health Technologies
    • Diamesco Co. Ltd.

第31章：其他領先和創新企業

  • Digital Medics Pvt Ltd.
  • Bigfoot Biomedical
  • Diabnext
  • Insulet Corporation
  • Jiangsu Delfu Medical Device Co. Ltd.
  • Sanofi India
  • Becton Dickinson
  • Biocon Ltd
  • Mehar healthcare
  • Johnson & Johnson
  • COVIDien Healthcare
  • Philips Healthcare India
  • Shandong WeiGao Group Medical Polymer Company Limited
  • Yuwell medical equipment & supply Co
  • Terumo

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年智慧胰島素筆市場：提供新機會的國家
  • 2029年智慧胰島素筆市場：細分市場帶來新機會
  • 智慧胰島素筆市場2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r25953u

Smart insulin pens refer to insulin delivery devices designed to monitor and record dosage information, including volume, time, and type. Additionally, these devices may offer functionalities such as generating reports for sharing with healthcare professionals.

Two primary types of smart insulin pens exist first-generation pens and second-generation pens (equipped with Bluetooth or USB connectivity). Second-generation smart insulin pens incorporate Bluetooth or USB features to facilitate closer monitoring. These pens come in either prefilled or reusable forms and are utilized for the treatment of both type 1 diabetes and type 2 diabetes. Smart insulin pens find application across various end-users, including hospitals and clinics, ambulatory surgical centers, as well as home care settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The smart insulin pens market research report is one of a series of new reports from The Business Research Company that provides smart insulin pens market statistics, including smart insulin pens industry global market size, regional shares, competitors with a smart insulin pens market share, detailed smart insulin pens market segments, market trends and opportunities, and any further data you may need to thrive in the smart insulin pens industry. This smart insulin pens market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart insulin pens market size has grown strongly in recent years. It will grow from $0.11 billion in 2024 to $0.11 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increase in diabetes prevalence, strong economic growth in emerging markets, increased geriatric population, increased healthcare expenditure and public health insurance reforms.

The smart insulin pens market size is expected to see strong growth in the next few years. It will grow to $0.15 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to an increase in disease burden, government initiatives and technological enhancements. Major trends in the forecast period include collaborating with technology companies, smart insulin delivery devices, new types of insulin delivery, integrating internet of things and increasing mergers and acquisitions.

The forecast of 7.0% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for dose-tracking microprocessors and precision injection mechanisms, key imports from Ireland and Israel, potentially delaying diabetes management solutions.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Achieving an accurate dose of insulin is more feasible with an insulin pen compared to a vial or syringe. For scenarios such as children requiring insulin during school hours and visually impaired diabetic patients, the insulin pen allows for pre-setting an accurate dose over the dosage dial, ensuring precise delivery at the time of injection. Pediatric-friendly insulin pens such as Novo Nordisk's Echo Plus enable half-unit dosing, with a maximum of 30 units. Other options such as Lilly's HumaPen Luxura HD allow insulin delivery in half-unit increments, and Novo Nordisk's NovoPen Junior offers highly accurate insulin doses, finely adjusting even in half-unit increments. The precision in dose adjustments and delivery offered by smart insulin pens can prevent both over-dosing and under-dosing, contributing to the expected increase in demand for smart insulin pens and driving market growth.

The rising global diabetic population is expected to significantly boost the growth of the smart insulin pen market in the coming years. The diabetic population consists of individuals diagnosed with diabetes, a chronic condition characterized by elevated blood glucose levels. Smart insulin pens enhance diabetes management by providing precise insulin dosage tracking, reminders, and data integration, which improves treatment adherence and overall glycemic control for those with diabetes. For example, in July 2022, the International Diabetes Federation, a Belgium-based non-profit organization, reported that approximately 537 million adults worldwide were living with diabetes in 2022. This figure is projected to rise to 643 million by 2030 and further to 783 million by 2045. Thus, the increasing global diabetic population is driving the growth of the smart insulin pen market.

The next generation of smart insulin pens extends well beyond simple memory storage, they assist in calculating personalized doses, continuously track glucose levels, and connect to smartphone apps for data visualization. In April 2022, Eli Lilly and Company, a U.S.-based multinational pharmaceutical firm, announced the Tempo(R) Personalized Diabetes Management Platform. This comprehensive system is designed to improve diabetes self-management for adults with type 1 and type 2 diabetes. The Tempo Smart Button is a reusable device that attaches to the Tempo Pen, capturing and transferring insulin dosing data, while the TempoSmart(TM) App logs these doses and offers personalized education and medication reminders.

Major companies in the smart insulin pens market are strategically focusing on introducing user-friendly insulin pens, such as the NovoPen 6 and the NovoPen Echo Plus, to optimize revenue in the market. These self-injection pens automatically record insulin dosing information for each injection. For instance, in March 2022, Novo Nordisk A/S, a Denmark-based pharmaceutical company, launched the first smart insulin pens-NovoPen 6 and NovoPen Echo Plus. These pens record details such as the timing and quantity of insulin administered, uploading the data to an app via near-field communication (NFC). The pens facilitate the transfer of insulin dosing information to a patient's preferred diabetes app, allowing data sharing with healthcare providers. They are compatible with smartphones, tablets, personal computers, blood glucose monitors, or other NFC-supported devices.

In October 2023, Novo Nordisk A/S acquired Biocorp, a France-based medical device company specializing in the development and manufacturing of drug-delivery systems and medical devices, for $164.5 million. This acquisition is expected to enable Novo Nordisk to further invest in Biocorp's device development and expedite its ambitions within devices and delivery solutions.

Major companies operating in the smart insulin pens market include Companion Medical, Novo Nordisk A/S, F. Hoffmann-La Roche AG, Emperra GmbH E-Health Technologies, Diamesco Co. Ltd., Digital Medics Pvt Ltd., Bigfoot Biomedical, Diabnext, Insulet Corporation, Jiangsu Delfu Medical Device Co. Ltd., Sanofi India, Becton Dickinson, Biocon Ltd, Mehar healthcare, Johnson & Johnson, Covidien Healthcare, Philips Healthcare India, Shandong WeiGao Group Medical Polymer Company Limited, Yuwell medical equipment & supply Co, Terumo, NIPRO, Olympus Medical Systems, Nihon Koden, Medtronic PLC, Ypsomed Holding AG, Berlin-Chemie AG, Patients Pending Ltd, Dexcom, Insujet, Eli Lilly., Abbott Laboratories, Tandem Diabetes Care, Inc.

North America was the largest region in the smart insulin pens market in 2024. Western Europe was the second largest region in the global smart insulin pens market share. The regions covered in the smart insulin pens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the smart insulin pens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The smart insulins pens market consists of sales of instruments such as first-generation pens and second-generation pens (Bluetooth enabled, USB connected). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Insulin Pens Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart insulin pens market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart insulin pens ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart insulin pens market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: First Generation Pens, Second Generation Pens
  • 2) By Usability: Prefilled, Reusable
  • 3) By Application: Type 1 Diabetes, Type 2 Diabetes
  • 4) By End User: Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings
  • Subsegments:
  • 1) By First Generation Pens: Basic Smart Insulin Pens With Standard Features; Simple Connectivity to Mobile Apps for Tracking and Logging Insulin Doses
  • 2) By Second Generation Pens: Advanced Smart Insulin Pens With Enhanced Features; Real-Time Data Sharing With Healthcare Providers and Caregivers; Sophisticated Mobile Applications for Comprehensive Diabetes Management
  • Companies Mentioned: Companion Medical; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Emperra GmbH E-Health Technologies; Diamesco Co. Ltd.; Digital Medics Pvt Ltd.; Bigfoot Biomedical; Diabnext; Insulet Corporation; Jiangsu Delfu Medical Device Co. Ltd.; Sanofi India; Becton Dickinson; Biocon Ltd; Mehar healthcare; Johnson & Johnson; Covidien Healthcare; Philips Healthcare India; Shandong WeiGao Group Medical Polymer Company Limited; Yuwell medical equipment & supply Co; Terumo; NIPRO; Olympus Medical Systems; Nihon Koden; Medtronic PLC; Ypsomed Holding AG; Berlin-Chemie AG; Patients Pending Ltd; Dexcom; Insujet; Eli Lilly.; Abbott Laboratories; Tandem Diabetes Care, Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Insulin Pens Market Characteristics

3. Smart Insulin Pens Market Trends And Strategies

4. Smart Insulin Pens Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Smart Insulin Pens Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Smart Insulin Pens PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Smart Insulin Pens Market Growth Rate Analysis
  • 5.4. Global Smart Insulin Pens Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Smart Insulin Pens Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Smart Insulin Pens Total Addressable Market (TAM)

6. Smart Insulin Pens Market Segmentation

  • 6.1. Global Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • First Generation Pens
  • Second Generation Pens
  • 6.2. Global Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prefilled
  • Reusable
  • 6.3. Global Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type 1 Diabetes
  • Type 2 Diabetes
  • 6.4. Global Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals & Clinics
  • Ambulatory Surgical Centres
  • Home Care Settings
  • 6.5. Global Smart Insulin Pens Market, Sub-Segmentation Of First Generation Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Basic Smart Insulin Pens With Standard Features
  • Simple Connectivity to Mobile Apps for Tracking and Logging Insulin Doses
  • 6.6. Global Smart Insulin Pens Market, Sub-Segmentation Of Second Generation Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Advanced Smart Insulin Pens With Enhanced Features
  • Real-Time Data Sharing With Healthcare Providers and Caregivers
  • Sophisticated Mobile Applications for Comprehensive Diabetes Management

7. Smart Insulin Pens Market Regional And Country Analysis

  • 7.1. Global Smart Insulin Pens Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Smart Insulin Pens Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Insulin Pens Market

  • 8.1. Asia-Pacific Smart Insulin Pens Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Insulin Pens Market

  • 9.1. China Smart Insulin Pens Market Overview
  • 9.2. China Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Insulin Pens Market

  • 10.1. India Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Insulin Pens Market

  • 11.1. Japan Smart Insulin Pens Market Overview
  • 11.2. Japan Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Insulin Pens Market

  • 12.1. Australia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Insulin Pens Market

  • 13.1. Indonesia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Insulin Pens Market

  • 14.1. South Korea Smart Insulin Pens Market Overview
  • 14.2. South Korea Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Insulin Pens Market

  • 15.1. Western Europe Smart Insulin Pens Market Overview
  • 15.2. Western Europe Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Insulin Pens Market

  • 16.1. UK Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Insulin Pens Market

  • 17.1. Germany Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Insulin Pens Market

  • 18.1. France Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Insulin Pens Market

  • 19.1. Italy Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Insulin Pens Market

  • 20.1. Spain Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Insulin Pens Market

  • 21.1. Eastern Europe Smart Insulin Pens Market Overview
  • 21.2. Eastern Europe Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Insulin Pens Market

  • 22.1. Russia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Insulin Pens Market

  • 23.1. North America Smart Insulin Pens Market Overview
  • 23.2. North America Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Insulin Pens Market

  • 24.1. USA Smart Insulin Pens Market Overview
  • 24.2. USA Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Insulin Pens Market

  • 25.1. Canada Smart Insulin Pens Market Overview
  • 25.2. Canada Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Insulin Pens Market

  • 26.1. South America Smart Insulin Pens Market Overview
  • 26.2. South America Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Insulin Pens Market

  • 27.1. Brazil Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Insulin Pens Market

  • 28.1. Middle East Smart Insulin Pens Market Overview
  • 28.2. Middle East Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Insulin Pens Market

  • 29.1. Africa Smart Insulin Pens Market Overview
  • 29.2. Africa Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Insulin Pens Market Competitive Landscape And Company Profiles

  • 30.1. Smart Insulin Pens Market Competitive Landscape
  • 30.2. Smart Insulin Pens Market Company Profiles
    • 30.2.1. Companion Medical Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Emperra GmbH E-Health Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Diamesco Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Smart Insulin Pens Market Other Major And Innovative Companies

  • 31.1. Digital Medics Pvt Ltd.
  • 31.2. Bigfoot Biomedical
  • 31.3. Diabnext
  • 31.4. Insulet Corporation
  • 31.5. Jiangsu Delfu Medical Device Co. Ltd.
  • 31.6. Sanofi India
  • 31.7. Becton Dickinson
  • 31.8. Biocon Ltd
  • 31.9. Mehar healthcare
  • 31.10. Johnson & Johnson
  • 31.11. Covidien Healthcare
  • 31.12. Philips Healthcare India
  • 31.13. Shandong WeiGao Group Medical Polymer Company Limited
  • 31.14. Yuwell medical equipment & supply Co
  • 31.15. Terumo

32. Global Smart Insulin Pens Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Insulin Pens Market

34. Recent Developments In The Smart Insulin Pens Market

35. Smart Insulin Pens Market High Potential Countries, Segments and Strategies

  • 35.1 Smart Insulin Pens Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Smart Insulin Pens Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Smart Insulin Pens Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer